
Am J Psychiatry 155:779-784, June 1998
© 1998 American Psychiatric Association
Apolipoprotein E 4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease
Minoru Yasuda, M.D.,
Etsuro Mori, M.D.,
Hajime Kitagaki, M.D.,
Hikari Yamashita, M.A.,
Nobutsugu Hirono, M.D.,
Kenichi Shimada, M.D.,
Kiyoshi Maeda, M.D., and
Chikako Tanaka, M.D., Ph.D.
OBJECTIVE: Diffuse brain atrophy is one of the gross pathological features of Alzheimer's disease and is a result of degenerative changes. The 4 allele of apolipoprotein E (APOE) is a risk factor or susceptibility gene in late-onset sporadic Alzheimer's disease and may influence the pathological changes associated with the disease. The aim of this study was to examine the relationship between the APOE 4 allele and whole brain atrophy. METHOD: Whole brain volume was quantified by using high-resolution magnetic resonance imaging and the computerized brain segmentation technique in 178 patients with late-onset sporadic Alzheimer's disease who carried no APOE 4 alleles (N=62), one 4 allele (N=93), or two (N=23) and had comparable clinical severity of dementia. RESULTS: An apparent positive correlation was found between normalized whole brain volume (relative to total intracranial volume) and number of APOE 4 alleles; i.e., patients carrying two APOE 4 alleles had the least brain atrophy. This association between the APOE 4 allele and brain volume was similar in women and men and was independent of age, level of education, duration of illness since symptom onset, and severity of dementia. CONCLUSIONS: The results indicate that cognitive dysfunction pro~gresses before severe brain atrophy develops in patients carrying the APOE 4 allele and suggest that an APOE 4-allele-related mechanism that affects neuronal function before a decrement in brain matter is involved in the development of dementia.
This article has been cited by other articles:

|
 |

|
 |
 
A. Drzezga, T. Grimmer, G. Henriksen, M. Muhlau, R. Perneczky, I. Miederer, C. Praus, C. Sorg, A. Wohlschlager, M. Riemenschneider, et al.
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Neurology,
April 28, 2009;
72(17):
1487 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Lane and M. R. Farlow
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
J. Lipid Res.,
May 1, 2005;
46(5):
949 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien
Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects
Neurology,
November 23, 2004;
63(10):
1892 - 1897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. De Stefano, M. L. Bartolozzi, B. Nacmias, V. Zipoli, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and M. P. Amato
Influence of Apolipoprotein E {epsilon}4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis
Arch Neurol,
April 1, 2004;
61(4):
536 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Haddock, W. S. C. Poston, and J. E. Taylor
Neurocognitive Sequelae Following Coronary Artery Bypass Graft: A Research Agenda for Behavioral Scientists
Behav Modif,
January 1, 2003;
27(1):
68 - 82.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hirono, M. Hashimoto, M. Yasuda, K. Ishii, S. Sakamoto, H. Kazui, and E. Mori
The effect of APOE {epsilon}4 allele on cerebral glucose metabolism in AD is a function of age at onset
Neurology,
March 12, 2002;
58(5):
743 - 750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hashimoto, M. Yasuda, S. Tanimukai, M. Matsui, N. Hirono, H. Kazui, and E. Mori
Apolipoprotein E {epsilon}4 and the pattern of regional brain atrophy in Alzheimer's disease
Neurology,
October 23, 2001;
57(8):
1461 - 1466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Whitwell, W. R. Crum, H. C. Watt, and N. C. Fox
Normalization of Cerebral Volumes by Use of Intracranial Volume: Implications for Longitudinal Quantitative MR Imaging
AJNR Am. J. Neuroradiol.,
September 1, 2001;
22(8):
1483 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
J Geriatr Psychiatry Neurol,
September 1, 2001;
14(3):
145 - 166.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R S Doody, S N Azher, H A Haykal, J K Dunn, T Liao, and L Schneider
Does APO epsilon 4 correlate with MRI changes in Alzheimer's disease?
J. Neurol. Neurosurg. Psychiatry,
November 1, 2000;
69(5):
668 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Bigler, C. M. Lowry, C. V. Anderson, S. C. Johnson, J. Terry, and M. Steed
Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype
AJNR Am. J. Neuroradiol.,
November 1, 2000;
21(10):
1857 - 1868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hirono, H. Kitagaki, H. Kazui, M. Hashimoto, and E. Mori
Impact of White Matter Changes on Clinical Manifestation of Alzheimer's Disease : A Quantitative Study
Stroke,
September 1, 2000;
31(9):
2182 - 2188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitagaki, N. Hirono, K. Ishii, and E. Mori
Corticobasal Degeneration: Evaluation of Cortical Atrophy by Means of Hemispheric Surface Display Generated with MR Images
Radiology,
July 1, 2000;
216(1):
31 - 38.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Barber, C. Ballard, I. G. McKeith, A. Gholkar, and J. T. O'Brien
MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia
Neurology,
March 28, 2000;
54(6):
1304 - 1309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Geroldi, M. Pihlajamaki, M. P. Laakso, C. DeCarli, A. Beltramello, A. Bianchetti, H. Soininen, M. Trabucchi, and G. B. Frisoni
APOE-{epsilon}4 is associated with less frontal and more medial temporal lobe atrophy in AD
Neurology,
November 1, 1999;
53(8):
1825 - 1825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mori, M. Ikeda, N. Hirono, H. Kitagaki, T. Imamura, and T. Shimomura
Amygdalar Volume and Emotional Memory in Alzheimer's Disease
Am J Psychiatry,
February 1, 1999;
156(2):
216 - 222.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Hirono, E. Mori, M. Yasuda, T. Imamura, T. Shimomura, M. Hashimoto, S. Tanimukai, H. Kazui, and H. Yamashita
Lack of Effect of Apolipoprotein E E4 Allele on Neuropsychiatric Manifestations in Alzheimer's Disease
J Neuropsychiatry Clin Neurosci,
February 1, 1999;
11(1):
66 - 70.
[Abstract]
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1998
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|